⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

XRTX News

XORTX Therapeutics Inc. Common Stock

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update